GlassScriptPhysician profile
David L Lichten
NPI 1366563744
$117,079.70
in general payments reported to CMS, 2019-2025
38 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85K · 2020: $29K · 2021: $270 · 2022: $616 · 2023: $1,342 · 2024: $465 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,079.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $88,395.27 | 2019-2020 | |
| Pacira Therapeutics, INC. | $20,631.09 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $4,119.87 | 2020 | |
| Collegium Pharmaceutical, INC. | $571.07 | 2019-2024 | Xtampza, Belbuca |
| Amgen INC. | $447.73 | 2020-2024 | Evenity, Prolia |
| Scilex Pharmaceuticals INC. | $439.38 | 2021-2025 | Ztlido |
| Abbott Laboratories | $429.93 | 2019-2025 | Eterna, Proclaim, Octrode |
| Boston Scientific Corporation | $332.43 | 2019-2024 | Wavewriter Alpha Prime 16 |
| Vertos Medical, INC. | $285.59 | 2019-2023 | Mild Device Kit |
| Nevro Corp. | $163.33 | 2022-2023 | Senza |
| Abbvie INC. | $160.13 | 2021-2023 | |
| Biodelivery Sciences International, INC. | $139.96 | 2019-2021 | |
| Almatica Pharma LLC | $125.00 | 2021-2023 | Gralise |
| Tersera Therapeutics LLC | $103.61 | 2019-2023 | Prialt |
| Saluda Medical Americas, INC. | $97.54 | 2025 | Evoke |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $86.58 | 2022-2023 | Dysport |
| Averitas Pharma INC. | $55.79 | 2023-2025 | Qutenza |
| Medtronic, INC. | $54.35 | 2025 | Inceptiv |
| Azurity Pharmaceuticals, INC. | $46.08 | 2023-2024 | Horizant, Horizant |
| Si-Bone, INC. | $37.49 | 2023 | |
| Assertio Therapeutics, INC. | $32.13 | 2019-2020 | |
| Foundation Fusion Solutions, LLC | $32.11 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $31.60 | 2021 | |
| Zyla Life Sciences, INC. | $27.02 | 2019 | |
| Bioventus LLC | $26.25 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $26.01 | 2023 | Seglentis |
| Fidia Pharma USA INC. | $24.64 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $17.33 | 2024 | Zilretta, Iovera |
| Ermi LLC | $16.21 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $16.15 | 2025 | |
| Ibsa Pharma INC. | $15.28 | 2022 | |
| Grt US Holding, INC. | $14.75 | 2020 | |
| Appliedvr INC | $14.23 | 2025 | Relievrx |
| Arbor Pharmaceuticals, INC. | $13.57 | 2021 | |
| Electronic Waveform Lab, INC. | $13.13 | 2021 | |
| Pfizer INC. | $12.98 | 2020 | |
| West Therapeutics Development, LLC | $12.51 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.58 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lichten listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.